Paul B Manning is a director of Liquidia Corp.
Person profile
Roles
Address
Charlottesville, Virginia
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G/A
Liquidia Corp
14 Feb 24
4
Liquidia Corp
18 Dec 23
4
Taysha Gene Therapies, Inc.
20 Nov 23
SC 13D/A
Taysha Gene Therapies, Inc.
21 Aug 23
4
Taysha Gene Therapies, Inc.
16 Aug 23
4
Verrica Pharmaceuticals Inc.
24 Jul 23
4
Candel Therapeutics, Inc.
29 Jun 23
4
Liquidia Corp
21 Jun 23
SC 13G/A
Pasithea Therapeutics Corp.
15 Feb 23
3
Pasithea Therapeutics Corp.
14 Feb 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Dec 23 | LQDA Liquidia | Common Stock | Buy | Acquire P | No | No | 7.16 | 279,330 | 2.00 mm | 279,330 |
17 Nov 23 | TSHA Taysha Gene Therapies | Common Stock | Buy | Acquire P | Yes | No | 1.63 | 100,000 | 163.00 k | 16,566,667 |
16 Aug 23 | TSHA Taysha Gene Therapies | Common Stock | Buy | Acquire P | Yes | No | 0.9 | 16,466,667 | 14.82 mm | 16,466,667 |
24 Jul 23 | VRCA Verrica Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 5.02 | 200,000 | 1.00 mm | 7,851,128 |
28 Jun 23 | CADL Candel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.22 | 14,240 | 17.37 k | 14,240 |